Clinical Trials in Montreal, QC

Browse 241 Montreal Medical Studies Across 992 Cities
111 Phase 3 Trial · 7347 Montreal Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Montreal, QC

Reviewed by Michael Gill, B. Sc.

Image of University of Pittsburgh Medical Center Health System - UPMC Department of Dermatology in Pittsburgh, United States.

Phase-Based Progress Estimates

Xevinapant (Debio 1143)for Head Neoplasms

1 Prior Treatment

This trial is testing a new cancer treatment against placebo to see if it is more effective in treating people with a certain type of head and neck cancer.

1 Prior Treatment

University of Pittsburgh Medical Center Health System - UPMC Department of Dermatology (+5 Sites)Medical ResponsibleEMD Serono Research & Development Institute, Inc.

Image of Alan Edwards Pain Management Unit - Montreal General Hospital in Montreal, Canada.

Phase-Based Progress Estimates

Gluten-free Dietfor Diet, Gluten-Free

Waitlist Available

This trial will test whether a gluten-free or low-FODMAP diet can help relieve symptoms of fibromyalgia and if these changes are linked to changes in gut bacteria.

Waitlist Available

Alan Edwards Pain Management Unit - Montreal General HospitalYoram Shir, MD

Image of Omega Research Consultants in Orlando, United States.

Phase-Based Progress Estimates

JNJ-78934804for Colitis, Ulcerative

This trial will compare the effectiveness of a new drug, JNJ-78934804, to existing treatments for ulcerative colitis.

Omega Research Consultants (+31 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of University of Washington in Seattle, United States.

Phase-Based Progress Estimates

JNJ-78934804for Crohn Disease

This trial is testing whether a new drug is better than existing drugs at treating psoriasis.

University of Washington (+47 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Clinical Trial Site in Myrtle Beach, United States.

Phase-Based Progress Estimates

ARV-110 In Combination With Abirateronefor Malignant Neoplasms

FDA Approved Drug

This trial is testing a new combination therapy for metastatic prostate cancer.

FDA Approved Drug

Clinical Trial Site (+11 Sites)Arvinas Androgen Receptor, Inc.

Image of Novo Nordisk Investigational Site in Montreal, Canada.

Phase-Based Progress Estimates

Part A: Oral Semaglutidefor cholesterol

FDA Approved Drug

In this study, four new tablet versions of two compounds will be investigated. The aim of this study is to investigate the amount of the active ingredient and helping agent in the blood after doses of four different tablet versions. The tablet versions, participants will receive, i.e. the treatment arm participants will be assigned to, is decided by chance. Participants will receive one treatment for 10 days in the first period. For the second period, directly following, participants will receive a different treatment for five more days. The study can last for up to approximately 10 weeks for each participant. This includes a screening period (up to 3 weeks), two treatment periods (together a total of 15 days) and a follow-up visit (5 weeks after the last dosing)

FDA Approved Drug

Novo Nordisk Investigational SiteClinical Transparency (dept. 1452)Novo Nordisk A/S

Image of Alaska Oncology and Hematology LLC in Anchorage, United States.

Phase-Based Progress Estimates

Bemarituzumabfor Cancer of Stomach

This trial is testing if adding the drug bemarituzumab to standard chemotherapy can help people with colorectal cancer live longer.

Alaska Oncology and Hematology LLC (+10 Sites)MDAmgen

Image of Desert Sky Dermatology in Gilbert, United States.

Phase-Based Progress Estimates

Ruxolitinibfor Dermatitis

FDA Approved Drug

This trial is testing whether ruxolitinib cream is an effective and safe treatment for children with Atopic Dermatitis. The trial is double-blind, meaning that neither the participants nor the researchers will know who is receiving the active treatment or the placebo until the trial is over. The trial is also stratified, meaning that the participants will be divided into groups based on their age and severity of Atopic Dermatitis.

FDA Approved Drug

Desert Sky Dermatology (+76 Sites)Brett Angel, MDIncyte Corporation

Image of Children's National Medical Center in Washington, United States.

Phase-Based Progress Estimates

DAY101for Glioma

This trial is studying a BRAF inhibitor as a possible treatment for pediatric, adolescent, and young adult patients with cancer.

Children's National Medical Center (+20 Sites)Day One Biopharmaceuticals, Inc.

Image of City of Hope (City of Hope National Medical Center, City of Hope Medical Center) in Duarte, United States.

Phase-Based Progress Estimates

PF-07284890for Carcinoma, Non-Small-Cell Lung

FDA Approved Drug

This trial is testing a new drug, PF-07284890, for safety and how well it works in people with BRAF V600-mutated solid tumors.

FDA Approved Drug

City of Hope (City of Hope National Medical Center, City of Hope Medical Center) (+63 Sites)Pfizer CT.gov Call CenterPfizer

Image of UCLA Medical Centre-Santa Monica in Santa Monica, United States.

Phase-Based Progress Estimates

JCAR017for Lymphoma, Diffuse

FDA Approved Drug

This trial is testing a new treatment for adult patients with relapsed or refractory (r/r) FL or MZL. The treatment consists of administration of JCAR017 on Day 1, after lymphodepleting (LD) chemotherapy. The study will assess the efficacy and safety of JCAR017 in these patients.

FDA Approved Drug

UCLA Medical Centre-Santa Monica (+32 Sites)Thalia Farazi, M.D./Ph.DCelgene

Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

Phase-Based Progress Estimates

Capecitabinefor Cancer of Colon

FDA Approved Drug

This trial tests how well ctDNA testing in the blood predicts treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there is very likely some small amounts of cancer that remain after surgery. However, this cancer, if detected, cannot be found on other tests usually used to find cancer, as it is too small. Testing for ctDNA levels may help identify patients with colon cancer after surgery who do benefit, and those who do not benefit, from receiving chemotherapy.

FDA Approved Drug

NRG Oncology - Pittsburgh Center (+99 Sites)Van K Morris

Image of University of California, Irvine in Orange, United States.

Phase-Based Progress Estimates

MN-166for Amyotrophic Lateral Sclerosis

This trial is testing a potential ALS treatment. It will last 18 months and compare the drug to a placebo.

University of California, Irvine (+24 Sites)Kazuko Matsuda, MD PhD MPHMediciNova

Image of Hamilton Health Sciences in Hamilton, Canada.

Phase-Based Progress Estimates

Edoxabanfor Brain Hemorrhage

FDA Approved Drug

This trial is testing whether a new blood thinner reduces the risk of stroke in people with a history of brain bleed.

FDA Approved Drug

Hamilton Health Sciences (+27 Sites)Ashkan Shoamanesh, MD. FRCPC

Image of Investigational Site Number 8400030 in Andalusia, United States.

Phase-Based Progress Estimates

Inhaled Long-Acting Beta Agonistfor Chronic Obstructive Airway Disease

Waitlist Available

FDA Approved Drug

This trial is testing a new medication to see if it can help people with COPD by reducing exacerbations and improving lung function.

Waitlist Available

FDA Approved Drug

Investigational Site Number 8400030 (+72 Sites)Clinical Sciences & OperationsRegeneron Pharmaceuticals

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Dinutuximabfor Neuroblastoma

FDA Approved Drug

This trial is testing a combination of drugs to treat neuroblastoma that has returned or is unresponsive to treatment. The drugs work in different ways to stop the growth of cancer cells.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Margaret E Macy

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Veliparibfor Glioblastoma

Waitlist Available

FDA Approved Drug

This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

Waitlist Available

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Matthias A Karajannis

Image of University Of Alabama At Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

Nivolumabfor Tumor, Colorectal

FDA Approved Drug

This trial is looking at a new combination treatment for people with colon or rectal cancer that has spread and who have already been treated.

FDA Approved Drug

University Of Alabama At Birmingham (+32 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Investigational Site Number 1240110 in Calgary, Canada.

Phase-Based Progress Estimates

Sarilumab SAR153191 (REGN88)for Arthritis, Juvenile

FDA Approved Drug

This trial is testing a new drug, sarilumab, for kids with sJIA to see what dose and regimen is best. They'll also look at how well it works and how safe it is.

FDA Approved Drug

Investigational Site Number 1240110 (+2 Sites)Clinical Sciences & OperationsSanofi

Image of Lewis and Faye Manderson Cancer Center in Tuscaloosa, United States.

Phase-Based Progress Estimates

Intensity-Modulated Radiation Therapyfor Carcinoma

Waitlist Available

This trial is studying whether whole-brain radiation therapy is more effective with or without hippocampal avoidance in treating patients with small cell lung cancer.

Waitlist Available

Lewis and Faye Manderson Cancer Center (+99 Sites)Vinai Gondi

Image of Pediatric Cardiology Clinic in Birmingham, United States.

Phase-Based Progress Estimates

Apixabanfor Venous Thromboembolism

FDA Approved Drug

This trial looks at whether the drug apixaban is safe and effective for children with a blood clotting disorder.

FDA Approved Drug

Pediatric Cardiology Clinic (+66 Sites)Pfizer CT.gov Call CenterPfizer

Image of Tom Baker Cancer Centre in Calgary, Canada.

Phase-Based Progress Estimates

Rituximabfor Lymphoma

FDA Approved Drug

This trial is testing new combinations of treatments against the current standard of care to see if they are more effective.

FDA Approved Drug

Tom Baker Cancer Centre (+12 Sites)John KuruvillaJanssen, LP

Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Phase-Based Progress Estimates

Intensity-modulated Radiation Therapyfor Adult Giant Cell Glioblastoma

Waitlist Available

FDA Approved Drug

This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.

Waitlist Available

FDA Approved Drug

Mayo Clinic Hospital in Arizona (+46 Sites)Minesh Mehta

Image of Riverside Methodist Hospital in Columbus, United States.

Phase-Based Progress Estimates

480Kd (CC-92480 + Carfilzomib + Dexamethasone)for Multiple Myeloma

This trial is testing a new drug, CC-92480, to see if it is more effective than the current standard of care for treating myeloma.

Riverside Methodist Hospital (+10 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Centre Hospitalier de l'Université de Montréal in Montreal, Canada.

Phase-Based Progress Estimates

On Demand ECMO (study Group)for Postoperative Complications

This trial is testing whether it's better to have cardiopulmonary support during a lung transplant only when needed (on demand), or to have it routinely.

Centre Hospitalier de l'Université de MontréalBasil Nasir, MD

25 Montreal Clinical Trials Near Me

Top Cities for Montreal Clinical Trials

Image of Montreal in Quebec.

Montreal

229Active Trials

Jewish General HospitalTop Active Site

Image of New York in New York.

New York

165Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site